CTLA4 and cancer: In the past few decades, critical breakthroughs have been made in the field of immune surveillance, including the involvement of PD-1/PD-L1 and CTLA-4 signaling pathways in the development and progression of cancers, which plays a vital role in the regulation of immune responses (Wu et al., 2020).